Back
Twist Bioscience 10K Form
Sell
48
TWST
Twist Bioscience
Last Price:
$46.84
Seasonality Move:
-16.9%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2020-08-12 | 10Q | TWST/Twist Bioscience Quarterly |
2020-05-13 | 10Q | TWST/Twist Bioscience Quarterly |
2020-02-10 | 10Q | TWST/Twist Bioscience Quarterly |
2019-12-13 | 10K | TWST/Twist Bioscience Annual |
2019-08-09 | 10Q | TWST/Twist Bioscience Quarterly |
2019-05-02 | 10Q | TWST/Twist Bioscience Quarterly |
Receive TWST News And Ratings
See the #1 stock for the next 7 days that we like better than TWST
TWST Financial Statistics
Sales & Book Value
Annual Sales: | $313M |
---|---|
Cash Flow: | $-17.3M |
Price / Cash Flow: | 0 |
Annual Sales: | $8.03 |
Price / Book: | 6.03 |
Profitability
EPS (TTM): | -3.60000 |
---|---|
Net Income (TTM): | $-208.7M |
Gross Margin: | $133.3M |
Return on Equity: | -38.12% |
Return on Assets: | -30.12% |
Twist Bioscience Earnings Forecast
Key Twist Bioscience Financial Ratios
-
The Gross Profit Margin over the past 9 years for TWST is 42.61%.
-
The Selling, General & Administrative Expenses for TWST have been equal to 69.78% of Gross Profit Margin.
-
The Research & Development expenses have been 29.03% of Revenue.
-
The Interest Expense is -0.01% of Operating Income.
-
The Net Earning history of TWST is -66.69% of Total Revenues.
-
Per Share Earnings over the last 9 years have been positive in 4 years.
Twist Bioscience Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Biotechnology |
Sector: | Health Care |
Current Symbol: | TWST |
CUSIP: | 90184D |
Website: | twistbioscience.com |
Debt
Debt-to-Equity Ratio: | 0 |
---|---|
Current Ratio: | 4.88 |
Quick Ratio: | 4.38 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 0 |
TWST Technical Analysis vs Fundamental Analysis
Sell
48
Twist Bioscience (TWST)
is a Sell
Is Twist Bioscience a Buy or a Sell?
-
Twist Bioscience stock is rated a SellThe current Twist Bioscience [TWST] share price is $47.99. The Score for TWST is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.